OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $69 | -100.0% | 13,383 | +5.9% | 0.01% | -70.6% |
Q2 2021 | $179,000 | -31.7% | 12,641 | -20.7% | 0.02% | -10.5% |
Q1 2021 | $262,000 | +77.0% | 15,938 | -18.1% | 0.02% | -24.0% |
Q3 2020 | $148,000 | -21.7% | 19,459 | -59.3% | 0.02% | +38.9% |
Q4 2019 | $189,000 | +509.7% | 47,820 | +374.2% | 0.02% | +800.0% |
Q3 2019 | $31,000 | -77.9% | 10,085 | -51.2% | 0.00% | -66.7% |
Q2 2018 | $140,000 | +6.9% | 20,672 | +2.6% | 0.01% | -14.3% |
Q1 2018 | $131,000 | -53.2% | 20,139 | -68.0% | 0.01% | -53.3% |
Q4 2017 | $280,000 | – | 63,020 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 5,618,424 | $46,801,000 | 100.00% |
Opaleye Management Inc. | 5,984,200 | $49,848,000 | 10.07% |
DELTEC ASSET MANAGEMENT LLC | 2,330,267 | $19,411,000 | 4.06% |
Corriente Advisors, LLC | 720,000 | $5,998,000 | 3.89% |
Versant Venture Management, LLC | 2,215,384 | $18,454,145,000 | 2.65% |
SV Health Investors, LLC | 312,068 | $2,600,000 | 1.80% |
Ikarian Capital, LLC | 2,055,977 | $17,126,000 | 1.36% |
EAM Global Investors LLC | 265,316 | $2,210,000 | 0.99% |
EAM Investors, LLC | 346,075 | $2,883,000 | 0.64% |
RA Capital Management | 2,727,272 | $22,718,000 | 0.44% |